Decay accelerating factor (DAF) and nucleic acids encoding it
US5763224A · kind A · utility
14Cited by
8References
33Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 19, 1994 |
| Grant date | Jun 9, 1998 |
| Priority date | — |
| Expiry date | Dec 19, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/829
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to nucleic acids encoding decay accelerating factor (hereinafter abbreviated as DAF), as well as vectors and cells which comprise such nucleic acids. Additionally, nucleic acids which encode variants of DAF, such as insertion, deletion or substitution variants, are described. This application also relates to the preparation of DAF in recombinant cell culture. In particular, it is concerned with the large scale manufacture of DAF suitable for pharmaceutical or diagnostic use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.